Influgrip is a food supplement containing a unique blend of Zinc and titrated extracts of Boswellia serrata and KalmCold (Andrographis paniculate extract). KalmCold is the only standardized extract of A. paniculata > 30% in andrographolide and made-up of seven different bioactives, clinically tested on over 400 individuals with the most common cold symptoms, whose results show a reduction in the duration and severity of the symptoms themselves. Influgrip contributes to the functionality of the upper respiratory tract and supports the body’s natural defences thanks to KalmCold™. Moreover Influgrip contains an extract of Boswellia serrata, which supports the joint functionality and counteracts localised states of tension (in association with Zinc which contributes to the normal immune system function and protection of cells from oxidative stress).

  • “Common cold” and “flu” are syndromes of familiar symptoms caused by viral infection of the upper respiratory tract. It is difficult to define the syndromes exactly because of great variation in the severity, duration, and types of symptom. The common cold syndrome has been defined in terms of experimental colds as a short mild illness with early symptoms of headache, sneezing, chilliness, and sore throat and later symptoms of nasal discharge, nasal obstruction, cough, and malaise. The influenza syndrome is typically of sudden onset and is characterized by fever, headache, cough, sore throat, myalgia, nasal congestion, weakness, and loss of appetite.


Understanding the symptoms of the common cold and influenza. Ron Eccles, Lancet Infect Dis. 2005 Nov; 5(11): 718–725.


  • 2 sachet/day, one in the morning and one in the afternoon, preferably


  • 12 sachets
Ingrediente per 2 bustine %VNR*
KalmCold (Andrographis paniculata
(Burm. f.) Nees) parti aeree e.s.
tit. >30% in andrografolide
200 mg
Boswellia serrata e.s.
tit. 20% in acidi boswellici
200 mg
Zinco 7,5 mg 75

*VNR: Valore nutritivo di riferimento

The Expert says

to learn more

Subscribe to the Newsletter

Subscribe to the newsletter to receive all the news.